Neuropharmacologist and Preclinical Central Nervous System (CNS) Research Consultant

Expertise

• Preclinical CNS research: Preclinical basic and applied CNS drug discovery research in the international pharmaceutical industry.
• A Neuropharmacologist and an accomplished drug hunter, with in-depth knowledge and broad expertise at the world's largest drug company.
• In-vitro neuropharmacology identifying new compounds in drug development and establishing new assay enhancements.
• Extensive preclinical evaluations for the advancement of drug candidates.
• Extensive knowledge of neurological and psychiatric disorders with a talent to lead and mentor scientists and project teams.
• Generate and advance novel ideas to testing in the laboratory setting.

Experience

Independent Consultant, Present

• Service large national and international pharmaceutical companies providing: Preclinical research, project management and visibility.
• Building teams and working with biologists, chemists, toxicologists and clinicians to develop novel drug products.

Pfizer Global Research and Development, Ann Arbor, MI, 2000 - 2007

Research Fellow and Sr. Research Associate, 1990 - 2007

• Provided scientific leadership of a team and influenced departmental and global therapeutic area goals and strategy.
• Supervised and mentored laboratory staff; supported methods of continuous innovative drug discovery and research.
• Enhanced the continued development of pharmaceutical business by collaborating with external academic sources.
• Served as project manager providing scientific leadership for a multidisciplinary team on drug discovery projects resulting in the goal-oriented advancement of several drug candidates to extensive preclinical evaluation as a prerequisite to clinical development for multiple indications.
• Led, supervised, and mentored a staff of associate scientists, post-doctoral researchers, and student interns in an in vitro neuropharmacology laboratory to successfully identify compounds for further development as potential drugs and to establish new assays enhancing drug discovery efforts.
• Evaluated staff performance, identifying development and promotional opportunities, and ensuring the availability of a properly trained and knowledgeable staff for future drug discovery projects.
• Communicated research priorities and deadlines, ensuring proper allocation of resources and staff, to efficiently support project goals.
• Championed novel ideas and conception records for drug discovery projects to successfully maintain cutting-edge competitiveness and intellectual property status.
• Researched, analyzed, and identified necessary resources and staff furthering progress in drug discovery.
• Maintained visible and proactive involvement in due diligence / licensing opportunities for cooperative scientific development.
• Initiated and maintained several international academic collaborations to enhance both drug discovery and basic research efforts as progressive development opportunities in the science.
• Broad strategic impact across business units and global therapeutic areas.

Goedecke AG, Frieburg, Germany, Research Scientist, 1985 - 1990

• Provided laboratory supervision, contributed to projects, initiated external collaborations.

Beecham Pharmaceuticals LTD., Harlow, U.K. Research Scientist, 1983 - 1984

• Provided laboratory supervision, contributed to projects, initiated external collaborations.

Ciba Geigy AG, Basel, Switzerland, Postdoctoral Research Scientist, 1980 - 1982

• Provided individual contributions, authored external publications, presented at scientific meetings.

Wellcome Research Laboratories, LTD., Beckenham U.K., Postdoctoral Research Scientist, 1980

• Provided individual contributions, supported transfer of technology.

Honors & Publications

Credentials

• Computer Software (Microsoft Office, GraphPad Prism and InStat)

Languages

• Fluent in German.

Academic and Professional Affiliations

• Society for Neuroscience (SFN), Member

Collegium Internationale Neuro-psychopharmacologicum (CINP), Member

Publications and Patents

• Published more than 50 papers in peer-reviewed journals, and presented at more than 70 international scientific meetings.
• Senior Author of a key opinion article - mechanism of action of the novel, marketed drugs.
• Responsible for seminar speaker series invitation of key opinion leaders to advance education of staff, state-of-the-art basic research, and drug discovery efforts.
• Initiated research or developed conceptions resulting in ten issued patents.

Education

• Ph.D. Neuropharmacology, University of Washington, Seattle, WA
• M.A. Psychopharmacology, Humboldt State University, Arcata, CA
• B.A. Physiological Psychology, Humboldt State University, Arcata, CA